CNS & Neurological Disorders-Drug Targets

Scope & Guideline

Empowering Scholars with Cutting-edge Pharmacological Insights

Introduction

Welcome to your portal for understanding CNS & Neurological Disorders-Drug Targets, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1871-5273
PublisherBENTHAM SCIENCE PUBL
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCNS NEUROL DISORD-DR / CNS Neurol. Disord.-Drug Targets
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 294, BUSUM 1400 AG, NETHERLANDS

Aims and Scopes

The journal "CNS & Neurological Disorders-Drug Targets" focuses on advancing the understanding and treatment of neurological disorders through innovative drug targets and therapeutic strategies. It encompasses a wide range of topics related to the central nervous system (CNS) and emphasizes the integration of pharmacological, biochemical, and molecular approaches to tackle neurological diseases.
  1. Pharmacological Research:
    The journal emphasizes pharmacological studies on various compounds, including natural products, synthetic drugs, and biologics, aimed at understanding their mechanisms of action in treating neurological disorders.
  2. Neurodegenerative Disorders:
    A significant focus is placed on neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS), exploring novel therapeutic targets and treatment paradigms.
  3. Neuroinflammation and Neuroprotection:
    Research related to neuroinflammation and neuroprotective strategies is a core area, addressing the role of immune responses and potential therapeutic interventions to mitigate neuroinflammatory damage.
  4. Neuropsychiatric Disorders:
    The journal also covers neuropsychiatric conditions, investigating the interplay between neurological and psychiatric symptoms, treatment efficacy, and new pharmacological approaches.
  5. Innovative Drug Delivery Systems:
    There is a keen interest in exploring novel drug delivery systems, including nanotechnology and transdermal systems, to enhance the efficacy of treatments for CNS disorders.
  6. Molecular Mechanisms and Biomarkers:
    The journal promotes research on molecular mechanisms underlying neurological disorders, including the identification of biomarkers for early diagnosis and monitoring of therapeutic responses.
The journal has been adapting to the latest advancements in neuroscience and pharmacology, leading to the emergence of several trending themes that are gaining traction in recent publications. These themes reflect the evolving landscape of neurological research and therapeutic strategies.
  1. Microbiome-Gut-Brain Axis:
    Recent studies have highlighted the significance of the microbiome-gut-brain axis in neurological disorders, indicating a growing interest in how gut health influences brain function and disease progression.
  2. Neuroinflammation as a Therapeutic Target:
    There is an increasing focus on neuroinflammation and its role in various neurological conditions, with research exploring anti-inflammatory strategies as potential therapeutic approaches.
  3. Nanotechnology in Drug Delivery:
    Emerging research on nanotechnology for drug delivery systems is gaining momentum, showcasing innovative methods to enhance the bioavailability and efficacy of treatments for CNS disorders.
  4. Genetic and Epigenetic Research:
    Investigations into genetic and epigenetic factors influencing neurological disorders are on the rise, emphasizing personalized medicine and targeted therapeutic interventions.
  5. Artificial Intelligence and Machine Learning:
    The integration of artificial intelligence and machine learning in analyzing neurological data is becoming a prominent theme, aiding in diagnosis, treatment planning, and outcome prediction.
  6. Phytochemicals and Natural Products:
    There is a renewed interest in the therapeutic potential of phytochemicals and natural products, with research focusing on their mechanisms of action and efficacy in neurological conditions.

Declining or Waning

While the journal continuously evolves with emerging research themes, certain topics have seen a decline in publication frequency or focus. These waning scopes may reflect shifting interests in the field or advancements in alternative therapeutic strategies.
  1. Traditional Herbal Medicine:
    The interest in traditional herbal remedies as standalone treatments has diminished, possibly due to an increasing focus on evidence-based pharmacological approaches and the need for standardized treatment protocols.
  2. Basic Animal Models:
    The reliance on basic animal models for studying neurological diseases appears to be waning, as there is a growing emphasis on more sophisticated models that better replicate human conditions and disease mechanisms.
  3. Single Agent Studies:
    Research focusing solely on the efficacy of single-agent therapies is declining, with a shift towards combination therapies that address the multifactorial nature of neurological disorders.
  4. Epidemiological Studies:
    There seems to be a reduction in the publication of purely epidemiological studies, as the journal increasingly prioritizes studies that integrate clinical findings with molecular and pharmacological research.

Similar Journals

Current Molecular Pharmacology

Connecting Researchers to Cutting-edge Pharmacological Insights
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-4672Frequency: 7 issues/year

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

International Journal of Molecular and Cellular Medicine

Empowering Research in Molecular Medicine and Beyond
Publisher: CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTERISSN: 2251-9637Frequency: 4 issues/year

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.

MEDICINAL RESEARCH REVIEWS

Transforming Research into Revolutionary Therapeutics
Publisher: WILEYISSN: 0198-6325Frequency: 6 issues/year

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

MOLECULAR THERAPY

Catalyzing advancements in patient-centered molecular therapies.
Publisher: CELL PRESSISSN: 1525-0016Frequency: 12 issues/year

MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.

Biomolecules & Therapeutics

Exploring Molecular Medicine for a Healthier Tomorrow
Publisher: KOREAN SOC APPLIED PHARMACOLOGYISSN: 1976-9148Frequency: 4 issues/year

Biomolecules & Therapeutics is a prominent journal published by the Korean Society of Applied Pharmacology, dedicated to advancing knowledge in the fields of Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. With an ISSN of 1976-9148 and an E-ISSN of 2005-4483, this journal serves as a vital platform for researchers and professionals to disseminate their findings from 2008 through 2024. Ranking in the Q2 category across multiple relevant fields, including Pharmacology and Drug Discovery, and consistently placing in the 60th to 70th percentiles in Scopus rankings, Biomolecules & Therapeutics exemplifies a commitment to high-quality research and scientific integrity. Although it operates on a traditional access model, readers can be assured of the journal's rigorous peer-review process, ensuring that published articles contribute meaningfully to ongoing discourse in pharmacological and biochemical research. Located in Seoul, South Korea, the journal stands at the forefront of innovation in healthcare, making it an essential resource for academics, students, and industry professionals alike.

NEUROMOLECULAR MEDICINE

Connecting Molecular Science with Neurological Health
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Unlocking the Secrets of Drug Action and Efficacy
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0022-3565Frequency: 12 issues/year

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

Letters in Drug Design & Discovery

Connecting Researchers to Shape Drug Development
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1808Frequency: 12 issues/year

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Illuminating Pathways in Biomedical Research with Insightful Articles.
Publisher: SCIENCE PRESSISSN: 1672-9145Frequency: 12 issues/year

ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.

Fluids and Barriers of the CNS

Unlocking the Mysteries of the CNS, One Barrier at a Time
Publisher: BMCISSN: 2045-8118Frequency: 1 issue/year

Fluids and Barriers of the CNS is a premier open-access journal published by BMC, dedicated to advancing the field of neuroscience by exploring the complexities of the fluid dynamics and barriers of the central nervous system. Since its inception in 2011, the journal has established itself as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and critical discussions in areas such as cellular and molecular neuroscience, developmental neuroscience, neurology, and miscellaneous medicine. With an impressive Q1 ranking across multiple categories in 2023, and strong performance metrics such as being ranked in the 93rd percentile in Developmental Neuroscience, this journal not only highlights cutting-edge research but also contributes to the ongoing dialogue surrounding neurophysiology and pathology. As an open-access journal based in London, United Kingdom, it ensures that high-quality research is accessible to a global audience, fostering collaboration and knowledge-sharing in the neuroscientific community.